公开(公告)号：US20120231080A1

公开(公告)日：2012-09-13

申请号：US13475118

申请日：2012-05-18

Applicant: Steven FRISBEE

Inventor： Steven FRISBEE

IPC: A61K9/14 ,  A61K31/155

CPC classification number: A61K9/2893 ,  A61K9/2009 ,  A61K9/2027 ,  A61K9/2846 ,  A61K9/2853 ,  A61K9/2866 ,  A61K31/135

Abstract: The invention provides stable controlled release monolithic coating compositions for use in coating pharmaceutical oral dosage forms comprising a polyglycol having a melting point greater than 55° C. and an aqueous dispersion of a neutral ester copolymer lacking functional groups.

Abstract translation: 本发明提供用于涂覆药物口服剂型的稳定的控释单片涂料组合物，其包含熔点大于55℃的聚二醇和缺乏官能团的中性酯共聚物的水分散体。

公开(公告)号：US20120231081A1

公开(公告)日：2012-09-13

申请号：US13475354

申请日：2012-05-18

Applicant: Steven FRISBEE

Inventor： Steven FRISBEE

IPC: A61K31/155 ,  A61K9/14

CPC classification number: A61K9/2893 ,  A61K9/2009 ,  A61K9/2027 ,  A61K9/2846 ,  A61K9/2853 ,  A61K9/2866 ,  A61K31/135

Abstract: The invention provides stable controlled release monolithic coating compositions for use in coating pharmaceutical oral dosage forms comprising a polyglycol having a melting point greater than 55° C. and an aqueous dispersion of a neutral ester copolymer lacking functional groups.

公开(公告)号：US20090142378A1

公开(公告)日：2009-06-04

申请号：US12328828

申请日：2008-12-05

Applicant: Steven FRISBEE

Inventor： Steven FRISBEE

IPC: A61K9/00 ,  A61K47/30 ,  A61K31/155

CPC classification number: A61K9/2893 ,  A61K9/2009 ,  A61K9/2027 ,  A61K9/2846 ,  A61K9/2853 ,  A61K9/2866 ,  A61K31/135

Abstract: The invention provides stable controlled release monolithic coating compositions for use in coating pharmaceutical oral dosage forms comprising a polyglycol having a melting point greater than 55° C. and an aqueous dispersion of a neutral ester copolymer lacking functional groups.

Abstract translation: 本发明提供用于涂覆药物口服剂型的稳定的控释单片涂料组合物，其包含熔点大于55℃的聚二醇和缺乏官能团的中性酯共聚物的水分散体。